These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26676809)

  • 1. The association between serious infection and disease outcome in patients with rheumatoid arthritis.
    Iguchi-Hashimoto M; Hashimoto M; Fujii T; Hamaguchi M; Furu M; Ishikawa M; Ito H; Yamakawa N; Terao C; Yamamoto K; Yamamoto W; Ohmura K; Mimori T
    Clin Rheumatol; 2016 Jan; 35(1):213-8. PubMed ID: 26676809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept.
    Tanaka Y; Yamanaka H; Saito K; Iwata S; Miyagawa I; Seto Y; Momohara S; Nagasawa H; Kameda H; Kaneko Y; Izumi K; Amano K; Takeuchi T
    Mod Rheumatol; 2012 Apr; 22(2):186-94. PubMed ID: 21901357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Etanercept Therapy on Disease Activity and Health-Related Quality of Life in Moderate Rheumatoid Arthritis Patients Population from a National British Observational Cohort.
    Kotak S; Mardekian J; Horowicz-Mehler N; Shah A; Burgess A; Kim J; Gemmen E; Boyd H; Koenig A
    Value Health; 2015 Sep; 18(6):817-23. PubMed ID: 26409609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year retrospective review of the incidence of serious infections in patients on biologic disease modifying agents for rheumatoid arthritis in three tertiary hospitals in Western Australia.
    Sharma C; Keen H
    Intern Med J; 2019 Apr; 49(4):519-525. PubMed ID: 30230146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis.
    Nair SC; Bijlsma JW; van der Werf JH; van der Veen MJ; Linn-Rasker SP; Vreugdenhil S; Lafeber FP; Welsing PM
    J Rheumatol; 2013 Sep; 40(9):1505-12. PubMed ID: 23818710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study.
    Lutf A; Poil AR; Hammoudeh M
    Int J Rheum Dis; 2014 Jan; 17(1):63-5. PubMed ID: 24472269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants associated with work participation in patients with established rheumatoid arthritis taking tumor necrosis factor inhibitors.
    Manders SH; Kievit W; Braakman-Jansen AL; Brus HL; Hendriks L; Fransen J; van de Laar MA; van Riel PL
    J Rheumatol; 2014 Jul; 41(7):1263-9. PubMed ID: 24833758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
    Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
    Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid arthritis disease activity and disability affect the risk of serious infection events in RADIUS 1.
    Weaver A; Troum O; Hooper M; Koenig AS; Chaudhari S; Feng J; Wenkert D
    J Rheumatol; 2013 Aug; 40(8):1275-81. PubMed ID: 23772079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice.
    Katayama K; Okubo T; Sato T; Ito H; Fukai R; Baba H
    Mod Rheumatol; 2015 Jan; 25(1):50-5. PubMed ID: 24983407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials.
    Smolen JS; Aletaha D; Grisar JC; Stamm TA; Sharp JT
    Ann Rheum Dis; 2010 Jun; 69(6):1058-64. PubMed ID: 19717399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis.
    Widdifield J; Bernatsky S; Paterson JM; Gunraj N; Thorne JC; Pope J; Cividino A; Bombardier C
    Arthritis Care Res (Hoboken); 2013 Mar; 65(3):353-61. PubMed ID: 22833532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
    Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
    J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypharmacy among people with rheumatoid arthritis: the role of age, disease duration and comorbidity.
    Treharne GJ; Douglas KM; Iwaszko J; Panoulas VF; Hale ED; Mitton DL; Piper H; Erb N; Kitas GD
    Musculoskeletal Care; 2007 Dec; 5(4):175-90. PubMed ID: 17623274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of medication adherence on disease activity among Japanese patients with rheumatoid arthritis.
    Nakagawa S; Nakaishi M; Hashimoto M; Ito H; Yamamoto W; Nakashima R; Tanaka M; Fujii T; Omura T; Imai S; Nakagawa T; Yonezawa A; Imai H; Mimori T; Matsubara K
    PLoS One; 2018; 13(11):e0206943. PubMed ID: 30388179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of tacrolimus on progression of joint damage in patients with rheumatoid arthritis.
    Motomura H; Matsushita I; Seki E; Mine H; Kimura T
    Int J Rheum Dis; 2014 Sep; 17(7):749-54. PubMed ID: 24251619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline comorbidities in patients with rheumatoid arthritis who have been prescribed biological therapy: a case control study.
    Espiño-Lorenzo P; Manrique-Arija S; Ureña I; Jiménez-Núñez FG; López-Lasanta M; Romero-Barco CM; Belmonte-López MA; Irigoyen MV; Fernández-Nebro A
    Reumatol Clin; 2013; 9(1):18-23. PubMed ID: 22938792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research Initiative.
    Ruban TN; Jacob B; Pope JE; Keystone EC; Bombardier C; Kuriya B
    Clin Rheumatol; 2016 Mar; 35(3):759-63. PubMed ID: 26245721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.